Pharmaceutical drug development embodies the intricate journey of transforming scientific discoveries into safe and effective medications. It is an intricate process that integrates multidisciplinary expertise, spanning from initial research to clinical trials and eventual regulatory approval.
At its inception, drug development involves identifying potential compounds through rigorous research, often driven by a deep understanding of biological mechanisms and disease pathways. These candidates then undergo preclinical testing to assess their safety, efficacy, and potential side effects. Upon successful preclinical evaluations, promising candidates advance to clinical trials, where they are meticulously tested on human subjects. This phase involves rigorous testing for safety, dosage determination, and efficacy across diverse patient populations. Clinical trials are pivotal, providing critical data that informs decisions on the drug's viability.
Post-approval, ongoing monitoring ensures the drug's safety and effectiveness in real-world settings. Continuous research and development efforts persist to refine existing medications and discover novel therapies, perpetuating the cyclical nature of pharmaceutical drug development.
In essence, pharmaceutical drug development is an intricate dance between scientific innovation, ethical considerations, and regulatory scrutiny, ultimately aimed at delivering safe, efficacious, and transformative medicines to improve global health.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico